Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
1.580
-0.010 (-0.63%)
At close: Dec 5, 2025, 4:00 PM EST
1.610
+0.030 (1.90%)
After-hours: Dec 5, 2025, 6:51 PM EST
Eledon Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 19.76 | 18.61 | 12.69 | 13.1 | 13.43 | 7.35 | |
| Research & Development | 66.7 | 51.96 | 30.31 | 26.68 | 23.44 | 5.93 | |
| Operating Expenses | 86.46 | 70.58 | 43 | 39.78 | 36.87 | 13.28 | |
| Operating Income | -86.46 | -70.58 | -43 | -39.78 | -36.87 | -13.28 | |
| Other Non Operating Income (Expenses) | 7.11 | 34.82 | -73.54 | 0.46 | 0.01 | 0.08 | |
| EBT Excluding Unusual Items | -79.36 | -35.75 | -116.54 | -39.32 | -36.86 | -13.2 | |
| Merger & Restructuring Charges | - | - | - | - | - | -5.18 | |
| Impairment of Goodwill | - | - | - | -48.65 | - | - | |
| Other Unusual Items | - | - | - | - | - | -4.83 | |
| Pretax Income | -79.36 | -35.75 | -116.54 | -87.97 | -36.86 | -23.22 | |
| Income Tax Expense | 0.43 | 0.43 | - | - | -2.35 | -0.4 | |
| Net Income | -79.79 | -36.18 | -116.54 | -87.97 | -34.51 | -22.81 | |
| Preferred Dividends & Other Adjustments | 2.88 | - | - | - | - | - | |
| Net Income to Common | -82.67 | -36.18 | -116.54 | -87.97 | -34.51 | -22.81 | |
| Shares Outstanding (Basic) | 75 | 49 | 25 | 14 | 15 | 1 | |
| Shares Outstanding (Diluted) | 75 | 49 | 25 | 14 | 15 | 1 | |
| Shares Change (YoY) | 94.74% | 97.18% | 72.34% | -3.61% | 921.03% | 121.42% | |
| EPS (Basic) | -1.10 | -0.75 | -4.73 | -6.16 | -2.33 | -15.72 | |
| EPS (Diluted) | -1.10 | -0.75 | -4.73 | -6.16 | -2.33 | -15.72 | |
| Free Cash Flow | -67.24 | -47.27 | -39.53 | -28.42 | -28.91 | -15.21 | |
| Free Cash Flow Per Share | -0.89 | -0.97 | -1.61 | -1.99 | -1.95 | -10.48 | |
| EBITDA | - | - | - | - | -36.86 | -13.28 | |
| D&A For EBITDA | - | - | - | - | 0.01 | 0.01 | |
| EBIT | -86.46 | -70.58 | -43 | -39.78 | -36.87 | -13.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.